Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $102.4400 (-2.8%) ($102.4400 - $102.4400) on Thu. Aug. 19, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.19% (three month average) | RSI | 17 | Latest Price | $102.4400(-2.8%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.2% a day on average for past five trading days. | Weekly Trend | LGND declines -2.3% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) IWM(56%) IWC(54%) IWN(51%) | Factors Impacting LGND price | LGND will decline at least -1.095% in a week (0% probabilities). VIXM(-27%) VXX(-17%) UUP(-17%) UNG(-4%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.095% (StdDev 2.19%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $98.59(-3.76%) | Resistance Level | $111.54 | 5 Day Moving Average | $105.85(-3.22%) | 10 Day Moving Average | $107.61(-4.8%) | 20 Day Moving Average | $111.54(-8.16%) | To recent high | -25.5% | To recent low | 0% | Market Cap | $1.646b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |